THRIVENT FINANCIAL FOR LUTHERANS - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 178 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.

Quarter-by-quarter ownership
THRIVENT FINANCIAL FOR LUTHERANS ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$644
-55.1%
129,535
-55.4%
0.00%
-66.7%
Q1 2023$1,435
-50.1%
290,507
-36.4%
0.00%
-57.1%
Q4 2022$2,874
-99.8%
456,876
+174.3%
0.01%
+40.0%
Q3 2022$1,799,000
+264.2%
166,590
+283.7%
0.01%
+400.0%
Q2 2022$494,000
-33.2%
43,414
-46.6%
0.00%0.0%
Q1 2022$740,000
-68.3%
81,287
-48.0%
0.00%
-75.0%
Q4 2021$2,333,000
+67.6%
156,339
+188.6%
0.00%
+33.3%
Q3 2021$1,392,000
+29.0%
54,179
+31.0%
0.00%
+50.0%
Q2 2021$1,079,00041,3550.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
VV Manager LLC 1,798,163$76,997,00067.53%
Wildcat Capital Management, LLC 1,515,524$64,895,00022.42%
TPG Group Holdings (SBS) Advisors, Inc. 19,716,306$844,252,00014.91%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 1,279,281$54,779,0007.69%
Coastal Bridge Advisors, LLC 463,117$19,831,0006.33%
DSAM Partners (London) Ltd 235,098$10,067,0002.63%
Casdin Capital, LLC 625,000$26,763,0001.58%
Alpine Global Management, LLC 150,000$6,423,0001.13%
Perceptive Advisors 1,543,790$66,105,0001.07%
Avoro Capital Advisors LLC 1,128,594$48,326,0000.96%
View complete list of ALLOGENE THERAPEUTICS INC shareholders